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The pathological damage caused by glaucoma is associated to a high intraocular pressure. The ocular hypertone is most likely
due to a defective efﬂux of aqueous humor from the anterior chamber of the eye. Ocular hypertension causes apoptotic death of
retinal ganglion cells and overexpression of molecular markers typical of cell stress response and apoptosis. In this work, we
report on the neuroprotective, antiapoptotic and antioxidant action of a natural substance, L-carnitine. This compound is known
foritsabilitytoimprovethemitochondrialperformance.Weanalyzeanumberofcellularandmolecularmarkers,typicalofocular
hypertension and, in general, of the cell stress response. In particular, L-carnitine reduces the expression of glial ﬁbrillary acidic
protein, inducible nitric oxide synthase, ubiquitin and caspase 3 typical markers of cell stress. In addition, the morphological
analysis of the optic nerve evidenced a reduction of the pathological excavation of the optic disk. This experimental hypertone
protocol induces a severe lipoperoxidation, which is signiﬁcantly reduced by L-carnitine. The overall interpretation is that
mortality of the retinal cells is due to membrane damage.
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The progression of glaucoma has been described in detail:
1,2
one of its main characteristics consists of a high intraocular
pressure (IOP), which raises above statistically normal
values. This increase can be ascribed, under a strictly
physical point of view, to a defective efﬂux of the aqueous
humor from the anterior chamber of the eye.
3 It has been
estimated that glaucoma is the second cause of blindness in
humansandthat68millionpatientssufferfromthis pathology,
about seven million individuals having bilateral blindness.
4
A common feature of the pathology involves an excavation of
the optic disk (cup-to-disk), which is extended to its margins.
Several studies indicate that the early lesions occur at the
level of the optical nerve, in particular, in the proximity of the
head of the optic nerve at the level of the lamina cribrosa;
however, it has also been suggested an initial involvement
of the retina.
5 Apoptotic death of the retinal ganglion cells
(RGCs) has been shown
6 and, in addition, the effect of the
intraocular hypertension causes a signiﬁcant overexpression
of caspase 3, which is a commonly accepted marker of
programmed cell death.
7,8 Death of a signiﬁcant number of
RGCs most likely reduces the number of the axons forming
the optic nerve. The evolution of this phenomenon results in
the pathological increase of the normal excavation of the optic
papilla, which eventually results in a serious vision deﬁcit.
9
The relevant role of micro- and macroglial cells in the
degeneration of RGCs has also been demonstrated.
10,11
Glial cells have a neuroprotective role, however, in a
pathological situation; they may contribute to neuron damage.
In particular, during progression of glaucoma, astrocytes
are involved in the remodelling of the lamina cribrosa and
they could act as initiators of the pathology.
12 Studies on
experimental models of ocular hypertension and human
glaucoma evidenced astrocyte hypertrophy and loss of
organization in both retina and optic nerve. The upregulation
oftheglialﬁbrillaryacidicprotein(GFAP)wasalsoobservedin
cultured astrocytes grown at high hydrostatic pressure.
13,14
The GFAP is considered a very important stress marker in
diverse retinal pathologies and in experimental models of
ocularhypertension.
8,15,16Activationoftheglialcellsmayalso
have noxious consequences on neurons, as they may cause
mechanical damages and alterations of the microenviro-
ment.
12,17 This triggers the release and/or production of
neurotoxic and proapoptotic compounds such as nitric oxide
synthase (NOS).
18,19 The nitric oxide (NO) thus produced is
a reactive free radical present in cells as a response to
increased intracellular concentrations of Ca
2þ.
20 It is known
that NOS increases in cerebral ischemia
21 and the over-
expression of this enzyme causes relevant tissue damage:
the overall result is a detrimental action on the cell
membrane.
21,22 Recent studies demonstrated that an excess
ofNOistoxicandthiscompoundincreasesasaconsequence
of ocular hypertension.
23 In glaucoma, the involvement of
inducible NOS (iNOS) has also been suggested.
24 The
oxidative stress and the increase of IOP also causes
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Ub-proteasome pathway:
8,25 this possibly derives from the
activation of the apoptotic program.
26–28 In this work, we
have explored the possibility that L-carnitine may modulate
theeffectsofocularhypertension.Thishypothesisisbasedon
the observation that this substance is able to improve the
mitochondrial metabolism
29 and has an antiapoptotic ac-
tion.
30,31 The action of L-carnitine is related to the improve-
ment of mitochondrial performance as defects of these
organelles have a key role in the completion of the apoptotic
process.
32,33 Several studies show that L-carnitine has a
neuroprotective action in different neurodegenerative pathol-
ogies such the syndromes of Parkinson and Alzheimer,
wherein mitochondrial malfunction and oxidative stress
are also observed.
34,35 The potential therapeutic role of
L-carnitine has been reported both for AIDS and ischemia
wherein apoptosis is also involved.
36,37 Its protective role has
been ascribed to the ability to inhibit the activation of the
caspase cascade.
30,31 It has been recently reported that, in
addition to L-carnitine, its acetylated derivative is also able to
reduce apoptosis in primary neuron cultures and in stable
mouse ﬁbroblast lines.
38 The antiapoptotic action was shown
to derive from the capacity of L-carnitine to restore and
stimulate typical mitochondrial functions such as the activity
of pyruvate dehydrogenase.
29,38 Considering all these, we
investigated the role of this compound in neuroprotection
and in the control of degenerative and apoptotic pheno-
mena. Finally, it has been reported that following ischemia/
reperfusion at retinal level, a considerable increase of lipid
peroxidation occurs.
39 Our data demonstrate that treatment
with L-carnitine signiﬁcantly reduces the level of membrane
peroxidation.
Results and Discussion
Carnitine reduces the expression of stress markers at
retinal level. After induction of the hypertensive stress
following methylcellulose (MTC) injection in the anterior
chamber, the expression of GFAP is increased at the level
of RGC and in the Muller cells as evidenced from the
morphological alterations of the retinal layers (Figure 1a, 3).
After induction of the hypertone and parallel treatment with
carnitine, the expression of this marker of glial cells is
signiﬁcantly reduced (Figure 1a, 2). In controls a basal
expression of GFAP is indeed observed, but this is
topographically limited to the inner retinal layer (Figure 1a, 1)
both in controls and in animals not subjected to the
hypertensive shock but simply treated with carnitine (not
shown). The reduced expression of this commonly accepted
marker of neuronal damage
8,16 is a clear indication that
carnitine is able to reduce the neurotoxic consequences of
the hypertensive stress.
InducibleNOS(iNOS)isknownasoneofthemainenzymes
involved in the mitochondrial lipid peroxidation and in
neuropathy.
20 As the neuronal damage is reduced, in our
experimental model by peroxide scavengers,
8 we examined
the possibility that the hypertensive shock could induce
upregulation of iNOS. The results reported in Figure 1b show
that the hypertension derived by administration of methyl-
cellulose
8 causes a dramatic increase of iNOS, which is
involved in the execution of the apoptotic pathway (lane 3).
Carnitine administered to the animal along with methyl-
cellulose strongly reduces the expression of this gene product
(lane 2). Therefore, carnitine improves the overall homeo-
static response to the hypertensive insult and is able to limit
apoptotic phenomena.
Induciblenitricsynthaseisoverexpressedinresponsetoan
oxidative stress and is also involved in the onset of apoptosis.
Literature data exist showing that the Ub-mediated protea-
some pathway is activated as a consequence of an oxidative
stress in retinal endothelial cells and in cultured cells.
25,26 The
result in Figure 1 shows that a basal level of ubiquitin is
detected in a total protein extract from control retinas (lane 1).
After induction of hypertone, a strong positivity to Ub is
detected (lane 3), which is signiﬁcantly reduced in the retina
concomitantly treated with carnitine (lane 2). The reduction of
Ub is a signal of improved cell homeostasis, which implies a
reduced protein degradation caused by the stress response.
As matter of fact, the activation of the Ub/proteasome
pathway is directly related to the execution of the apoptotic
death.
8,26–28 In conclusion, carnitine is able to mediate a
reduction of the stress markers whose upregulation is caused
by the hypertensive stress due to the MTC treatment in the
experimental glaucoma. As carnitine reduces the intracellular
concentration of typical markers of cell sufferance and/or
apoptosis, our data strongly suggest that the drug exerts a
negative control on the progression of apoptotic death at
retinal cell level.
Apoptotic cell death consequent to the ocular hypertone
is controlled in the presence of carnitine. To assess
weather carnitine can actually reduce the execution of
apoptosis after induction of the hypertone, we evaluated
the extent of cell death by TUNEL staining and detection of
a commonly accepted marker of apoptosis: caspase 3. This
double assessment is necessary as the TUNEL ﬂuorescent
reaction may generate ambiguous results. As a matter of
fact, this method is not sufﬁciently speciﬁc to discriminate
Figure 1 Reduction of the expression of stress markers at retinal level induced
by carnitine. (a) Immunolocalization of GFAP assessed by immunoﬂuorescence
in rat retina. 1: retina from untreated control eye. 2: Contralateral eye treated
with methylcellulose in the presence of carnitine. 3: Eye treated only with
methylcellulose. Magniﬁcation was  500 in all cases. (b) Western blot on total
proteinfromretinaextractstoassesstheexpressionofiNOS,ubiquitinanda-tubulin
as standard reference. In this and subsequent ﬁgures, lanes 1, 2, and 3 report the
results obtained in the same experimental conditions as in panel a; that is: control,
MTC plus L-carnitine and MTC alone
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Cell Death and Diseasebetween necrosis and apoptosis in spite of the fact that this
method is often utilized to evaluate this type of cell death.
40
Figure 2a shows the results of a typical TUNEL ﬂuorescent
reaction in the presence (2) and in the absence (3) of
carnitine. Results show that the drug strongly reduces the
ﬂuorescent reaction. This can be rationalized as a decrease
of DNA fragmentation as this process is associated with cell
death at the level of astrocytes and RGCs. Caspase 3 is
a protease involved in the triggering and execution of
apoptosis. Data shown in Figure 2b evidenced that in
hypertensive/MTC-treated retinas, a dramatic expression of
caspase 3 occurs (lane 3). The level of this enzyme is
strongly reduced if the hypertensive shock is paralleled
by treatment with carnitine (lane 2). Therefore we can
reasonably conclude that the drug is able to reduce
signiﬁcantly the execution of the cell death program.
It is known that carnitine has a role in membrane
stabilization and function. In particular, this compound is
involved in the transport of long-chain fatty acid at the level
of the mitochondrial membrane.
29–31,35 This results in an
improved energy metabolism, which counteracts possible cell
death processes activated at mitochondrial level, as also
suggested in a previous work on an analogous acetylated
molecule. As a matter of fact, the mitochondrial membrane
stabilization is supported by the observation that administra-
tion of acetylcarnitine to cultured cells decreases the release
of cytochrome c from the mitochondria.
38 On the basis of
the observations, we hypothesized that carnitine, a natural
substance normally produced in the organism, could limit
apoptosis by a reduction of lipid peroxidation. This reduction
would stabilize the mitochondrial membrane thus improving
the overall energy metabolism. This hypothesis was probed
measuring the production of malondialdehyde (MDA) gener-
ated at membrane level after oxidative.
Morphological analysis of the glaucomatous cupping of
the optic disk. Pathological optic-disk cupping is very often
caused by glaucoma. Many different causative agents, not
associated with elevated IOP or glaucomatous optic nerve
disease, may result in pathological optic nerve excavation.
In a previous work a signiﬁcant pathological cupping of
the heads of the optic nerve, as a consequence of loss of
astrocytes and nerve ﬁbers, was observed.
8 However, in the
case of a hypertensive treatment in the presence of carnitine,
a dramatic reduction of the eye to cup phenomenon is
observed (Figure 3). Optic-disk cupping is a consequence of
myriad disorders, but in this case its reduction is evidently
due to a reduced oxidative insult, which also produces a
better control of cell homeostasis with consequent rescue of
astrocytes and nerve ﬁbers.
The oxidative stress induces an increase of membrane
damage. The extent of membrane damage was assessed
by measuring the production of MDA, a widely recognized
marker of lipoperoxidation whose production occurs in cells
directly from a damage to the membrane structure and
function. Samples treated with MTC, on the other hand, show
extensive lipoperoxidative damage, as shown by the very
high cytoplasmic MDA concentration (Figure 4a, bar to the
left). However, the data presented here clearly show that
carnitine is able to only moderately protect the cells from the
apoptotic death due to oxidative stress. As a matter of fact,
the MDA levels monitored in retinas treated with this
compound in the presence of methylcellulose are only
mildly reduced (Figure 4a, central bar), and therefore the
apoptotic cell death monitored in our model system is not
only due to an oxidative stress. As matter of fact, carnitine
reduces the production of MDA but does not restore the cell
vitality: thus MTC induces apoptosis by mechanisms that are
not solely ascribable to mitochondrial damage.
In summary, the injection of methylcellulose into the
anterior chamber of the eye activates diverse cellular and
molecular signals of stress at the level of RGCs, such as the
upregulation of the GFAP and DNA damage. Methylcellulose
essentially hinders the efﬂux of ﬂuids from the canals of
Schlemm. This increases the IOP, which eventually results in
the establishment of an oxidative stress. This stress is shown
by the overexpression of iNOS, an enzyme primarily involved
Figure 2 Carnitine reduces apoptotic cell death consequent to the ocular
hypertone. (a) Evaluation of DNA damage by TUNEL assay. Magniﬁcation was
 500 in all cases. (b) Western blot on retina total protein extracts to assess the
expression of caspase 3. Data shown in 1, 2 and 3 report in the same order the
results obtained in the experimental conditions as in Figure 1
Figure 3 Morphologicalalterationsofcup-to-eye.Controlretinalsamples(1);methylcellulosetreatedretinasinthepresence(2);orabsenceof carnitine(3).Magniﬁcation
was  500 in all cases
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Cell Death and Diseasein the mitochondrial lipid peroxidation, with consequent
damage of the cell membrane, which is validated by the
accumulation of intracellular MDA: a hallmark of lipoperoxida-
tion. The Ub-mediated proteasome pathway is also activated
and this is directly related to the execution of the apoptotic
death as shown by the stimulation of caspase 3 expression.
The antiapoptotic role of carnitine is illustrated in (Figure 4b).
This compound has a key role in the stabilization and function
of the cell membrane. Treatment with methylcellulose in
parallel with carnitine reduces the level of all markers of cell
sufferance and apoptotis. In conclusion, by enhancing the
mitochondrial performance, carnitine also improves the over-
all homeostatic response to the hypertensive insult and limits
apoptotic phenomena.
Materials and Methods
Animal maintenance, induction of hypertone and carnitine
treatment. Male adult Wistar rats were used throughout the work. All
experimental procedures were in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research, and the guidelines of the
Institutional Animal Care and Use Committee. General anesthesia was done by
intraperitoneal injection of a nonbarbiturate anesthetic in physiological solution
administered according to the supplier recommendations (sodium-thiopental
solution (Farmotal, Pharmacia & Upjohn, USA)). Local anesthesia was done by
administration of eye drops of 0.4% oxibuprocaine (Novesine, Novartis, Basel,
Switzerland). Ocularhypertensionwas inducedaccordingto a methoddevelopedin
ourlaboratory.Brieﬂy,animalswereinjectedintheanteriorchamberoftheright eye
with MTC (Sigma-Aldrich, St. Louis, MO, USA) in physiological solution. The
contralateral eye was used as control and injected only with physiological solution.
The IOP was monitored by tonometry (Tonopen XL, Automated Ophthalmics,
Ellicott City, MD, USA). For further details refer Calandrella et al.
8 Treatments with
L-carnitine (Sigma-Tau, Industrie Farmaceutiche Riunite, Pomezia Roma, Italy)
were done by dissolving the drug in a methylcellulose suspension at the indicated
concentrations. The ﬁnal concentration of carnitine is referred to the volume, about
300±20ml, as estimated by weighing the content of each control eye.
Morphological, molecular analysis of tissue sections and of
retina total protein extracts
Sample preparation. Eyes were removed and the corneas were eliminated at
limbus level; vitreous humor and crystalline lens were discarded. The samples thus
obtained were ﬁxed in 4% paraformaldehyde for 6h at 41C and quickly washed in
PBS. Samples were then soaked in a 30% sucrose solution for 6–8h at 41C, ﬁnally
included in freezing resin (OCT, Killik, Bio-Optica, Milan, Italy) and cryostat-cut in
longitudinal sections (10-mm thick).
Cell biology assays. Immunolocalization was performed on GFAP. Sections
were dehydrated, treated with Triton X 100 (0.1% v/v) for 30min and blocked
in 1% bovine serum albumin for the same time. Endogenous peroxidases
were neutralized with hydrogen peroxide (0.3% in PBS for 20min). GFAP was
evidenced by an anti-GFAP (Sigma-Aldrich) and a ﬂuoresceinated ﬂuorescent
secondary antibody (Alexa Fluor, Molecular Probes). Fixed sections were stained
with 0.1% hematoxylin QS for 1min (nuclear chromatin); after washing in PBS,
tissuesectionswereincubatedfor2minin1%eosintostainthecytoplasm;thisstep
was followed by optical microscope observation.
DNA fragmentation was evidenced by TUNEL reaction(in situ cell
death detection kit, AP/Roche)
Biomolecular assays. Western blottings and lipoperoxidation assays were
performedoncontrolandcarnitine-treatedretinalcellextracts.Totalproteinextracts
were prepared by standard procedures and analyzed by PAGE using the following
antibodies: caspase 3 active form, iNOS (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) and Ub (Sigma-Aldrich). a-Tubulin was used as standard reference
(Sigma-Aldrich).
To determine the oxidative stress at membrane level, we used a quantitative
assaybasedon the intracellular productionof MDAmeasured bythe commercialkit
LPO-586 (Oxis Health Research Products Portland, OR, USA). The chromophore,
N-methyl-2-phenylindole (NMP) reacts with MDA after incubation at 451C. A single
MDAmoleculereactswithNMP moleculesgeneratingastablechromophorewhose
absorbance can be spectrophotometrically measured at a 586nm. Absorbance
values can be directly converted in molar concentration of MDA.
Statistical analysis. All the experiments were repeated at least three times.
Statistical analysis of results was made by the Student’s t-test or by a two-way
analysis of variance followed by the Student’s t-test. P-values o0.05 were
considered signiﬁcant.
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